OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles.

So here is a new title

This one has got the charts at the top again & has a link to the old one.
http://www.moneyam.com/InvestorsRoom/posts.php?tid=5021

Expect a BIG movement in the next 7 days - back to July levels.

?? Why ??

you're sounding like me!!

Why?

RESULTS DATE: 12 MARCH 2009

Oxford, UK - 25 February 2009: Oxford BioMedica (LSE: OXB), a leading gene therapy company, announces today that it will be releasing its preliminary results for the twelve months ended 31 December 2008 on Thursday, 12 March 2009.



Analyst meeting: An analyst briefing will be held at 09:30 am on Thursday, 12 March 2009 at the offices of Buchanan Communications, 45 Moorfields, London EC2Y 9AE.



Web cast: Simultaneously to the analyst briefing at 09:30 am, there will be a live audio web cast of the presentation. To connect to the web cast facility, please go to the Company's website: http://www.oxfordbiomedica.co.uk/ approximately 10 minutes (09:20 am) before the start of the briefing. This will also be available for replay shortly after the presentation.

Nice rise of 25%. Can't see any reason why but seems to follow the trend of some stocks atm. Perhaps MM's are starting to mark some of these up at last.

45% is a nice mark-up eh. I find similar movement with PDX and GFM which have been dormant for too long.

see FTSE thread

Low volumes, MM playing games, don't get locked in!

FWIW, I think MM's are marking up stocks whenever there is any demand, partly to get more for the stock they may hold from earlier, but more-likely to get some folks to sell ( to satisfy the Buyers).
Thus there is no need to panic-buy - unless you believe this stock is really worth much more - my av. is about 35p, so some way to go, yet.

Some good news for OXB this morning:

OXB - new collaboration agreement with Sanofi-Aventis

'The initial payment from Sanofi-Aventis significantly strengthens Oxford BioMedica's financial resources. As a result, with pro forma net cash as at 31 December 2008 of approximately 51 million, the Directors estimate that current cash is sufficient to support the Company's operations into 2012.'

heres hoping it helps drive the stock up - lets see what the outcome of the anylysts meeting is?

Sure it's good News, but it only confirms a belief - it is not in itself a profit-stream . . . althjough maybe closer than anything else the Market reacts to.
+I note that Pendragon is up 44% on new financing - sure that means "certainty", but you can bet it will cost and there may be strings . . . . (I don't hold [PEND], yet).

EDIT (010609)-Up to 10p mid on RNS that Trovax is getting good reveiws.

some good news again for trovax at last

Looks like this is really starting to move up now - so glad I bought back and seeing a profit!

OXB recently presented at a major international conference: "In all trials, TroVax was well tolerated with no serious adverse events..."

Another pleasant surprise to come home to!
OXB and a few other 'minnows' are presenting at the Piper Jaffray Fourth Annual Europe Conference in London this week (24th or thereabouts).

Webcast today at 09:30 on:
www.oxfordbiomedica.co.uk

to discuss today's RNS:
"Oxford BioMedica is committed to further development of TroVax with a partner and expressions of interest from prospective partners have already been received. Following the positive outcome of the FDA's review, the Company is implementing a broad partnering initiative and is also progressing discussions with clinical trial networks and clinicians who may conduct independent studies of TroVax."

For full details go to:
Positive review by FDA for further development and trials of TroVax

Good morning all>


Great news for all investorsTrovex as was expected is still alive and kickinga partnership deal must be imminent.hopefully a 30% SP rise today as a starterfingers crossed.
.................................
Martin C-J - 30 Jun'09 - 12:39 - 809 of 866

romust - I just talked to OXB and they are just waiting for the actual communication from the FDA to arrive. Any day or moment now. And I don't think there are any nasty surprises.

how good does news have to be to get a rise???

Clearly the "news" isn't all that good, witness sp drifting down! - This "news" just means thaty the FDA accepts that OXB (and their Agents) made a fist of (the failed) Trovax trial-recruitment. That's my "take" FWIW.
This is a bit like the England Cricket Team asking the Umpire to "press Reset" because they are wearing the wrong outfit.

The worry now (IMHO) is that OXB needs to tread carfully so that their "replacement trial" is sufficiently "random" to please the FDA, without cries of "Foul!" . . . . I suspect OXB needs to become more-involved in the patient selection and avoid countries that would use the "treatment" as a form of "National Health" - er, if I understand the nature of the earlier-problem.

It might be better to recruit only genuine english-speaking patients (from Europe and N.America), so at least there is a decent chance any rogues can be eliminated before the trials start.

My other concern is that by permitting this "poor" Trial (now stopped), the Directors of OXB have demonstrated that a cartload of Monkeys would not make a worse fist of wasting Investor's investment by pouring "time" down the drain...er, it says here...the sp was well over 30p until this Trial flopped.

I accept that the outcome is OXB now have "more Cash" (Hooray!) and that "Trovax" appears to be well-tolerated - that is a great relief, then.